Roy Lau
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 15
- CAR-T cell therapy research 7
- Cancer Cells and Metastasis 5
- Immunology 14
- Immunotherapy and Immune Responses 12
- T-cell and B-cell Immunology 5
- Co-authors
- Jeffrey S. Weber (11 shared papers)Alan J. Korman (2 shared papers)James S. Economou (7 shared papers)William H. McBride (5 shared papers)John A. Glaspy (5 shared papers)Lisa H. Butterfield (4 shared papers)Jon Kuniyoshi (3 shared papers)Wenshi Wang (1 shared paper)
- Journals
- Journal of Immunotherapy (3 papers)International Immunology (2 papers)Human Gene Therapy (2 papers)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Roy Lau
32 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 84
- Immunology 1.2k
- Oncology 878
- Genetics 378
- Molecular Biology 660
- Biotechnology 78
Countries citing papers authored by Roy Lau
This map shows the geographic impact of Roy Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Lau more than expected).
Fields of papers citing papers by Roy Lau
This network shows the impact of papers produced by Roy Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Lau. The network helps show where Roy Lau may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Lau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A comparison of gene transfer methods in human dendritic cells. | 1997 | 265 |
| 2 | 2009 | 230 | |
| 3 | 2001 | 188 | |
| 4 | 2007 | 186 | |
| 5 | 1998 | 132 | |
| 6 | 2001 | 131 | |
| 7 | 1999 | 83 | |
| 8 | In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. | 1996 | 68 |
| 9 | 1997 | 62 | |
| 10 | 2020 | 54 | |
| 11 | 2021 | 48 | |
| 12 | 1998 | 46 | |
| 13 | 2020 | 46 | |
| 14 | 2002 | 45 | |
| 15 | 2003 | 45 | |
| 16 | 2004 | 36 | |
| 17 | A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma. | 2003 | 33 |
| 18 | 2021 | 32 | |
| 19 | 2004 | 29 | |
| 20 | 1997 | 19 |
About Roy Lau
Roy Lau is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Biomedical Engineering, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (7 papers), Virus-based gene therapy research (7 papers), T-cell and B-cell Immunology (5 papers), RNA Interference and Gene Delivery (5 papers), Cancer Cells and Metastasis (5 papers), 3D Printing in Biomedical Research (4 papers) and Thyroid Disorders and Treatments (3 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (878 citations), Genetics (378 citations), Molecular Biology (660 citations) and Biotechnology (78 citations). Roy Lau has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Jeffrey S. Weber, Alan J. Korman, James S. Economou, William H. McBride, John A. Glaspy, Lisa H. Butterfield, Jon Kuniyoshi, Wenshi Wang, Daohai Yu and Weiwei Zhu. Their work appears in journals such as Journal of Immunotherapy, International Immunology, Human Gene Therapy, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.